Nintedanib Soft Gelatin Capsule 150 MG

Get a Price/Quote

MOQ : 10 Boxes

Nintedanib Soft Gelatin Capsule 150 MG Specification

Dosage Form
Capsule

Life Span
24 months from manufacturing date

Origin of Medicine
India

Packaging Type
Blister pack or box

Brand Name
As per label (varies by manufacturer)

Salt Composition
Nintedanib 150 mg

Indication
Treatment of idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and other chronic fibrosing interstitial lung diseases

Pacakaging (Quantity Per Box)
Typically 30 or 60 capsules per box

Drug Type
Allopathic

Ingredients
Nintedanib

Physical Form
Soft Gelatin Capsule

Function
Anti-fibrotic, inhibits multiple tyrosine kinases involved in the pathway of fibrosis

Recommended For
Interstitial lung diseases, Idiopathic pulmonary fibrosis, and other fibrotic lung conditions

Dosage
150 mg per capsule, as directed by physician

Dosage Guidelines
Take orally with food, swallow whole, do not crush or chew

Suitable For
Adults

Quantity
10 capsules per strip

Storage Instructions
Store below 30C, protect from moisture and light

Side Effects
Common side effects include diarrhea, nausea, abdominal pain, vomiting, and elevated liver enzymes

Route of Administration
Oral

Therapeutic Class
Antifibrotic agent / Tyrosine kinase inhibitor

Manufacturing License Number
As per pack (varies by manufacturer)

Prescription/Non-Prescription
Prescription

Contraindications
Hypersensitivity to Nintedanib or its excipients, pregnancy

Marketed By
Names and details as per packaging, commonly Indian pharma companies

Color of Capsule
Yellowish or as per manufacturer

Nintedanib Soft Gelatin Capsule 150 MG Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

Nintedanib Soft Gelatin Capsule 150 MG About

Introducing the Elite Nintedanib Soft Gelatin Capsule 150 MG-a first-class, new generation anti-fibrotic agent featured for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and chronic fibrosing interstitial lung diseases. With its enviable yellowish soft gelatin form and ultimate oral delivery, this prescription medication is manufactured in India by renowned pharmaceutical companies. Each capsule delivers 150 mg Nintedanib, a trusted tyrosine kinase inhibitor. Storage is recommended below 30C; dosing as prescribed. Please note, it is contraindicated in pregnancy and hypersensitivity cases.

Therapeutic Excellence and Core Applications

Nintedanib Soft Gelatin Capsule 150 MG is used for the ultimate management of idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and other fibrotic lung conditions in adults. Its core application lies in inhibiting multiple tyrosine kinases to slow disease progression. Administered orally, the soft gelatin capsule is swallowed whole with food, providing targeted antifibrotic effects within lung tissue for optimal patient benefits.

Packing, Pricing, and Delivery Valuation

Nintedanib 150 MG capsules come in elite blister packs, available in boxes of 30 or 60. Each pack is safeguarded to preserve quality during Packing & Dispatch. List price and valuation may vary with supplier and packaging details, commonly supplied from Indian FOB ports. Standard delivery time is prompt and coordinated to ensure product freshness and swift market access, guaranteeing ultimate satisfaction for traders and healthcare providers.

FAQ's of Nintedanib Soft Gelatin Capsule 150 MG:

Q: How should Nintedanib Soft Gelatin Capsules 150 MG be taken for best results?

A: Nintedanib capsules should be taken orally with food, swallowing them whole without crushing or chewing. Follow your physician's dosage instructions carefully for optimal therapeutic results.

Q: What conditions are primarily treated using Nintedanib 150 MG capsules?

A: These capsules are indicated for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and other chronic fibrosing interstitial lung diseases in adults.

Q: When can patients expect to see benefits from starting Nintedanib therapy?

A: Improvements vary with individual response, but the goal is to slow disease progression. Treatment should be continued as directed by a healthcare provider, with regular assessments to monitor efficacy and manage side effects.

Q: What are the common side effects associated with this therapy?

A: Common side effects may include diarrhea, nausea, abdominal pain, vomiting, and elevated liver enzymes. It is important to promptly report severe or persistent symptoms to a healthcare professional.

Q: Where is Nintedanib 150 MG manufactured and supplied from?

A: Nintedanib Soft Gelatin Capsules are primarily manufactured and supplied by leading Indian pharmaceutical companies, with packaging and licensing details specified per individual pack.

Q: What makes Nintedanib 150 MG a suitable option for fibrotic lung conditions?

A: Its mechanism as an antifibrotic and tyrosine kinase inhibitor effectively targets the pathways involved in fibrosis, offering patients a first-class treatment option that helps slow disease progression.

Tell us about your requirement